INSM - Company ID 0001104506
The table below shows INSMED Inc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$935.01M | -$683.88M | -$536.25M | -$400.44M | -$363.30M | -$219.35M |
| Capital expenditure | $32.56M | $21.92M | $13.29M | $9.88M | $7.29M | $6.24M |
| Investing cash flow | -$64.58M | -$583.17M | -$223.60M | -$34.58M | -$64.28M | -$6.82M |
| Dividends paid | - | - | - |
INSMED Inc reported operating cash flow of -$935.01M for fiscal year 2025. That is down 36.7% from -$683.88M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$146.71M (FY 2016) to -$935.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $954.07M | $1.34B | $168.44M | $793.27M | $612.55M | $271.00M |